Tag:
RSV
Latest Headlines
Latest Headlines
AstraZeneca's MedImmune gets RSV candidate fast-tracked
Two Maryland-based companies are racing to get a vaccine for respiratory syncytial virus to market--and one just picked up a regulatory boost.
THE LIBRARY: WEBINAR
FDA's Expedited Development and Approval Programs
FDA's Breakthrough Therapy, Accelerated Approval, Priority Review, and Fast Track may speed product approval. In this webinar, David Shoemaker will explain the differences, describe strategies to determine which program may be right for you, and discuss FDA requirements for each. Register Now!
EVENTS
- PMI Global Congress 2015 - North AmericaOctober 11-13, 2015 — Orlando, FL — Sponsored By: PMI
- BioImmersionOctober 14-16 — Chicago, IL — Sponsored by: Biotech Primer
- Drug Development ImmersionNovember 19-20 — Boston, MA — Sponsored by: BioTech Primer
Press Releases
- Alvogen Launches the First Generic Exelon® Patch in the United States
- First U.S. Patient Treated With Revolutionary Automatic Brain Metastases Planning Software by Brainlab
- Bioline Launches New EPIK miRNA Panel Assays
- Presbia to Complete Second Stage Enrollment in the US FDA Pivotal Study of Presbia Flexivue Microlens
- Thoratec Announces Start Of Shield II™ U.S. Clinical Trial
- More Press Releases
Sponsored Links